Abstract
Background: Acyclovir is usually given as protracted therapy
and at greater dosing frequency for complete remittance of the
disease due to its low oral bioavailability, but this is associated
with side effects. Topical preparations of acyclovir are the
alternative route of administration to treat local dermatological
diseases caused by herpes simplex virus.
Objective: To prepare and evaluate the topical gel formulations
of acyclovir by using different polymers.
Materials and Methods: Acyclovir gels were formulated by
using three types of polymers, namely carboxymethylcellulose
sodium (CMC Na), hydroxypropyl methylcellulose (HPMC) and
carbopol-940 as gelling agents at different concentrations. They
were evaluated for several physicochemical characteristics
including physical appearance, grittiness, viscosity, spreadability,
pH, drug content uniformity and in vitro drug release studies. The
in vitro drug release of acyclovir from the selected gel
formulations was evaluated as per the procedure described in
United States Pharmacopoeia (USP), by using the standard 40mesh stainless steel dissolution basket (USP Apparatus 1)
containing cellulose acetate membrane with phosphate buffer pH
6.8 as the dissolution medium.
Results: Among all prepared gel formulations, formulation F8
containing 3% w/w of carboxymethylcellulose sodium was
selected as optimal gelling agent in acyclovir gel formulation due
to its desired physicochemical characteristics and it showed the
highest acyclovir in vitro release rate of 96.21 ± 0.92% over 5
hours.
Conclusion: The release of acyclovir from the gel formulations
was significantly affected by the type and concentration of
polymer (p-value < 0.05).
References
James SH, Prichard MN. Current and Future Therapies for
Herpes Simplex Virus Infections: Mechanism of Action and
Drug Resistance. Current Opinion in Virology. 2014; 8: 54-
Cortesi R, Esposito E. Acyclovir Delivery Systems. Expert
Opinion on Drug Delivery. 2008; 5 (11): 1217-1230.
Patel S, Jain P, Parkhe G. Formulation and Evaluation of
Acyclovir Loaded Novel Nano-Emulsion Gel for Topical
Treatment of Herpes Simplex Viral Infections. Journal of
Drug Delivery and Therapeutics. 2018; 8 (5-s): 265–270.4. Satheesh Madhav NV, Ojha A. Labial Mucosa as a Novel
Transmucosal Drug Delivery Platform. International Journal
of Pharmacy and Pharmaceutical Sciences. 2012; 4 (3): 83-
Kikwai L, Babu RJ, Prado R, Kolot A, Armstrong CA, Ansel
JC, et al. In Vitro and In Vivo Evaluation of Topical
Formulations of Spantide II. AAPS PharmSciTech. 2005;
(4): E565-572.
Tanwar YS, Jain AK. Formulation and Evaluation of Topical
Diclofenac Sodium Gel Using Different Gelling Agent. Asian
Journal of Pharmaceutical Research and Health Care. 2012; 4
(1): 1-6.
Parchuri DB, Shantha Kumar GS, Goli D, Karki R.
Formulation and Evaluation of Nanoparticulate Drug
Delivery System of Acyclovir for Topical Drug Delivery.
World Journal of Pharmacy and Pharmaceutical Sciences.
; 2 (6): 5602-5617.
Helal DA, El-Rhman D, Abdel-Halim SA, El-Nabarawi MA.
Formulation and Evaluation of Fluconazole Topical Gel.
International Journal of Pharmacy and Pharmaceutical
Sciences. 2012; 4 (5): 176-183.
Garg A, Aggarwal D, Garg S, Singla AK. Spreading of
Semisolid Formulations: An Update. Pharmaceutical
Technology North America. 2002; 26 (9): 84-105.
United States Pharmacopoeia–National Formulary (USP37–
NF32). Vol. 1. Rockville (MD): United States Pharmacopeial
Convention; 2014. Physical Tests <711> Dissolution; p. 344.
Dongare US, Chemate SZ, Jadhav SA, Pawar VR.
Spectrophotometric Determination and Validation of
Acyclovir in Tablet Dosage Form. International Journal of
PharmTech Research. 2012; 4 (4): 1840-1845.
International Conference on Harmonisation (ICH) of
Technical Requirements for Registration of Pharmaceuticals
for Human Use. ICH, Q2 (R1) - Validation of Analytical
Procedures: Text and Methodology. Geneva, Switzerland:
ICH Harmonised Tripartite Guideline; 2005.13. Kumar BK, Thiruvengada Rajan VS, Begum NT. Analytical
Method Development and Validation of Lidocaine in
Ointment Formulation by UV Spectrophotometric Method.
International Journal of Pharmacy and Pharmaceutical
Sciences. 2012; 4 (2): 610-614.
Macedo T, Block LH, Shukla AJ. Release of Tolmetin from
Carbomer Gel Systems. Drug Development and Industrial
Pharmacy. 2008; 19 (8): 887-902.
Kaur LP, Garg R, Gupta GD. Development and Evaluation of
Topical Gel of Minoxidil from Different Polymer Bases in
Application of Alopecia. International Journal of Pharmacy
and Pharmaceutical Sciences. 2010; 2 (3): 43-47.
Farage MA, Hood W, Berardesca E, Maibach H. Intrinsic and
Extrinsic Factors Affecting Skin Surface pH. Current
Problems in Dermatology. 2018; 54: 33-47.
United States Pharmacopoeia–National Formulary (USP37–
NF32). Vol. 2. Rockville (MD): United States Pharmacopeial
Convention; 2014. Official Monographs: Acyclovir; p. 1616.
Kaur D, Raina A, Singh N. Formulation and Evaluation of
Carbopol 940 Based Glibenclamide Transdermal Gel.
International Journal of Pharmacy and Pharmaceutical
Sciences. 2014; 6 (8): 434-440.
Taş C, Ozkan Y, Savaşer A, Baykara T. In Vitro and Ex Vivo
Permeation Studies of Chlorpheniramine Maleate Gels
Prepared by Carbomer Derivatives. Drug Development and
Industrial Pharmacy. 2004; 30 (6): 637-647.
United States Pharmacopoeia–National Formulary (USP37–
NF32). Vol. 1. Rockville (MD): United States Pharmacopeial
Convention; 2014. General Information <1092> The
Dissolution Procedure: Development and Validation; p. 8
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright (c) 2024 Asia Pacific Journal of Health Sciences and Research